Other clinicopathological parameters, including patient age, sex, histological grade, pathologic T stage, overall cancer stage, and the presence of lymph node metastasis were not associated with LOXL2 expression (p > 0.05 for all). This evidence concerns the gene LOXL2 and metastatic malignant neoplasm in the lymph nodes.